We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SJM:NYSEThe J.M. Smucker Company Analysis

Data as of 2026-09-07 - not real-time

$126.08

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The J. M. Smucker Company trades at $126.08, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 6.6%. Relative strength is 53.9 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $115.82 and resistance around $135.89.
Multiples put this in fair territory at a P/E of 58.9. The average analyst target implies 12.2% above today's level. Revenue is growing at 5.0% on a 2.5% profit margin. The 3.55% dividend yield looks stretched against payout coverage.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 29.1%, a beta of -0.28 and a maximum drawdown of 22.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 2/10 long-term conviction.

Top Market Events

Updated Aug 5, 2026 0 ORRVILLE, Ohio, Aug.Packaged foods company J.M Smucker NYSE:SJM reported in Q2 CY2026, with sales up 5% year on year to $2.22 billion. Its...SJM stock has benefited from the Hostess acquisition and solid earnings, with the shares posting a s

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 106.82
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Dividend yield of 3.55% looks stretched against payout coverage
  • Trading above the 200-day average of 106.82

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Dividend yield of 3.55% looks stretched against payout coverage
  • Analyst targets imply +12.2% versus the current price
  • P/E ratio of 58.9

Key Metrics & Analysis

Financial Health

Revenue Growth5.00%
Profit Margin2.51%
P/E Ratio58.9
ROE3.93%
ROA6.26%
Debt/Equity120.68
P/B Ratio2.4
Op. Cash Flow$1.9B
Free Cash Flow$1.5B

Technical Analysis

TrendBullish
RSI53.9
Support$115.82
Resistance$135.89
MA 20$124.89
MA 50$119.48
MA 200$106.82
MACDBearish
VolumeIncreasing
Fear & Greed Index94.32

Valuation

Fair Value$150.31
Target Price$141.44
Upside/Downside12.18%
GradeFair
TypeBlend
Dividend Yield3.55%

Risk Assessment

Beta-0.28
Volatility29.05%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.